Loading…
Zoetis Inc. is projected to rise to $92.15 by 2027, a +22% move from its current price of $75.56. ZTS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $74.37 | $75.59 | $76.84 | +0.04% |
| Jul 14 | $73.90 | $75.63 | $77.39 | +0.09% |
| Jul 15 | $73.55 | $75.66 | $77.83 | +0.13% |
| Jul 16 | $73.27 | $75.69 | $78.20 | +0.18% |
| Jul 17 | $73.02 | $75.73 | $78.54 | +0.22% |
| Jul 18 | $72.79 | $75.76 | $78.85 | +0.26% |
| Jul 19 | $72.59 | $75.79 | $79.13 | +0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $72.59 | $75.79 | $79.13 | +0.31% |
| Week 2 | $71.53 | $76.03 | $80.81 | +0.62% |
| Week 3 | $70.77 | $76.26 | $82.18 | +0.93% |
| Week 4 | $70.18 | $76.50 | $83.39 | +1.24% |
| Week 5 | $69.68 | $76.73 | $84.50 | +1.55% |
| Week 6 | $69.25 | $76.97 | $85.54 | +1.87% |
| Week 7 | $68.88 | $77.21 | $86.54 | +2.18% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
The company markets its products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health.
It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
Zoetis Inc., symbol ZTS, is currently priced at $71.86 and has a market capitalization of $30.13B. It ranks 445.
The near- to mid-term price outlook is guided by a year-by-year forecast that starts with a 2026 profile near the current price and expands into a bullish multi-year path. The 2026 forecast shows a low of $71.86, an average of $71.86, and a high of $97.35, with an ROI of 0% and a neutral sentiment.
Longer-term projections indicate growing averages and positive ROI across the horizon, with 2030 averaging $99.02 and a bullish stance, rising further through 2040 and 2050. For example, 2040 is forecast to average $193.49 and 2050 to average $322.13, underscoring a strong multi-year outlook.
A major floor 12.4% below — a decisive break under it would weaken the trend.
The nearest floor, 4.9% below — buyers have tended to step in here.
The nearest ceiling, 8.8% above — a clean break opens room to run.
A major ceiling 66.7% above — clearing it would confirm fresh momentum.
Key ZTS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ZTS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $75.49 | Buy | $75.26 | Buy |
| MA 10 | $74.59 | Buy | $75.40 | Buy |
| MA 20 | $76.54 | Sell | $76.62 | Sell |
| MA 50 | $82.08 | Sell | $84.25 | Sell |
| MA 100 | $101.36 | Sell | $96.20 | Sell |
| MA 200 | $115.55 | Sell | $112.02 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.32 | Neutral |
| Stoch RSI (14) | 92.59 | Sell |
| CCI (20) | -32.45 | Neutral |
| Williams %R (14) | -41.36 | Info |
| MACD (12,26,9) | 0.55 | Buy |
| ROC (12) | -1.67 | Sell |
| Bollinger %B (20,2) | 0.40 | Neutral |
| Stochastic %K (14) | 58.64 | Neutral |
| TRIX (15) | -0.47 | Sell |
| Awesome (5,34) | -2.18 | Sell |
| Ultimate (7,14,28) | 64.25 | Neutral |
| Momentum (10) | -2.26 | Sell |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 75.93 | Sell |
| ADX (14) | 27.38 | Sell |
| ATR (14) | 1.25 | Info |
Near term, sentiment is NEUTRAL, with RSI14 at 30. The stock is trading below both the 50-day and 200-day moving averages, which sit at $88.11 and $118.06 respectively.
Support is at $71.86 and resistance at $82.20, framing the near-term technical landscape. The 30-day price range spans from $63.80 to $80.94, providing a sense of the current volatility and potential trading bands.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $71.86 | $75.56 | $102.81 | 0% | Neutral | |
| $75.47 | $92.15 | $117.63 | +22% | Bullish | |
| $80.09 | $99.63 | $130.62 | +32% | Bullish | |
| $84.37 | $106.57 | $142.69 | +41% | Bullish | |
| $81.93 | $104.89 | $142.98 | +39% | Bullish | |
| $85.98 | $111.41 | $154.26 | +47% | Bullish | |
| $88.82 | $116.40 | $163.46 | +54% | Bullish | |
| $95.20 | $126.07 | $179.34 | +67% | Bullish | |
| $112.78 | $150.83 | $217.13 | +100% | Bullish | |
| $114.83 | $155.03 | $225.65 | +105% | Bullish | |
| $147.13 | $207.18 | $316.02 | +174% | Bullish | |
| $232.81 | $351.59 | $574.88 | +365% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $71.86 | $75.56 | $90.76 | +0.00% |
| August 2026 | $67.35 | $78.84 | $94.27 | +4.33% |
| September 2026 | $66.88 | $78.65 | $94.79 | -0.23% |
| October 2026 | $67.14 | $79.29 | $96.19 | +0.81% |
| November 2026 | $69.49 | $82.35 | $100.45 | +3.86% |
| December 2026 | $70.53 | $83.86 | $102.81 | +1.83% |
Click any year to see its month-by-month ZTS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ZTS price prediction for 2026 points to an average of $75.56 (low $71.86, high $102.81) — a potential gain of 0% on today's $75.56. Price action looks broadly range-bound.
In 2027, ZTS is projected to trade between $75.47 and $117.63, averaging $92.15 — a potential gain of +22% from today's $75.56. That is up +22% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Zoetis Inc.'s 2028 outlook centres on $99.63, within a $80.09 to $130.62 range. That is up +8% on the projected 2027 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2029, ZTS could reach as high as $142.69, with a base case around $106.57 and support toward $84.37 — roughly +41% from $75.56. Buyers look set to stay in control over this stretch.
Expect ZTS to range from $81.93 to $142.98 through 2030. The $104.89 average target implies a +39% move from current prices. That is -2% versus the projected 2029 average. Momentum favours further upside here.
The ZTS price prediction for 2031 points to an average of $111.41 (low $85.98, high $154.26) — a potential gain of +47% on today's $75.56. Buyers look set to stay in control over this stretch.
In 2032, ZTS is projected to trade between $88.82 and $163.46, averaging $116.40 — a potential gain of +54% from today's $75.56. That is up +4% on the projected 2031 average. Momentum favours further upside here.
Zoetis Inc.'s 2033 outlook centres on $126.07, within a $95.20 to $179.34 range. That is up +8% on the projected 2032 average. That marks a +67% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, ZTS could reach as high as $217.13, with a base case around $150.83 and support toward $112.78 — roughly +100% from $75.56. Momentum favours further upside here.
Expect ZTS to range from $114.83 to $225.65 through 2035. The $155.03 average target implies a +105% move from current prices. That is up +3% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The ZTS price prediction for 2040 points to an average of $207.18 (low $147.13, high $316.02) — a potential gain of +174% on today's $75.56. Momentum favours further upside here.
In 2050, ZTS is projected to trade between $232.81 and $574.88, averaging $351.59 — a potential gain of +365% from today's $75.56. That is up +70% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ZTS today (≈ 13.234516 ZTS) could be worth
$4,653.18
+$3,653.18 (+365%) by 2050 · US Dollar
Based on the average projected ZTS price of $351.59 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ZTSwould be worth at today's price.
$1,000 invested in ZTS on Jul 10, 2025 (≈ 6.297229 ZTS) would be worth
$475.82
-$524.18 (-52.4%) today · 0.48× · US Dollar
Based on a ZTS entry price of $158.8 vs. today's $75.56.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $74.8 | $1,010.16 | +1.0% |
| 1 month ago | $81.29 | $929.51 | -7.0% |
| 3 months ago | $117.86 | $641.1 | -35.9% |
| 6 months ago | $125.32 | $602.94 | -39.7% |
| 1 year ago | $158.8 | $475.82 | -52.4% |
| All time (5.0y) ago | $199.31 | $379.11 | -62.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ZTS forecast.
Our base-case forecast reaches $150.00 around 2034.
Implied market cap at $150.00: $62.88B
The multi-year forecast shows a bullish drift starting in 2027 and continuing through 2050, with higher average prices and substantial ROI over time. In 2027, the average is $87.41 with ROI 21.6% and bullish sentiment. The 2028 average is $94.57 (ROI 31.6%), and the 2029 average is $100.10 (ROI 39.3%).
The 2030 average settles at $99.02 with ROI 37.8% while remaining bullish.
Further years show continued upside: 2031 average $104.84 (ROI 45.9%), 2032 average $108.26 (ROI 50.6%), 2033 average $118.34 (ROI 64.7%), 2034 average $141.76 (ROI 97.3%), and 2035 average $143.50 (ROI 99.7%), all with bullish sentiment.
The forecast extends to 2040 with an average of $193.49 (ROI 169.3%) and to 2050 with an average of $322.13 (ROI 348.3%), maintaining a bullish stance. These figures are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $99.02 with a min of $77.32 and a max of $135.05, and a projected ROI of 37.8% with bullish sentiment.
The forecast shows bullish sentiment from 2027 onward, with rising averages and positive ROI through 2050, starting at 21.6% in 2027 and climbing to 348.3% by 2050; these are estimates, not guarantees.
Yes. In 2029 the average is $100.10, with a min of $79.22, a max of $134.11, and an ROI of 39.3%, with bullish sentiment.
The 2040 forecast shows an average of $193.49, with a min of $137.38, a max of $295.22, an ROI of 169.3%, and bullish sentiment.
Zoetis Inc. Community Discussion
0Share your Zoetis Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.